Revenue: The sum of all revenue fields included for a company's operating activities.
Elite Pharmaceuticals Inc. (ELTP) had Revenue of $32.36M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$32.36M |
$5.91M |
|
$18.85M |
|
$13.51M |
|
$24.83M |
|
$7.53M |
|
$0.19M |
|
$7.72M |
|
$7.72M |
|
$5.91M |
|
$5.91M |
|
$5.91M |
|
$5.91M |
|
$7.53M |
|
$8.03M |
|
1.08B |
|
1.13B |
|
$0.01 |
|
$0.01 |
|
| Balance Sheet Financials | |
$114.49M |
|
$10.74M |
|
$25.18M |
|
$139.67M |
|
$30.44M |
|
$3.53M |
|
$4.40M |
|
$34.84M |
|
$104.83M |
|
$100.04M |
|
$104.83M |
|
1.08B |
|
| Cash Flow Statement Financials | |
$10.07M |
|
$-0.81M |
|
$-0.11M |
|
$30.27M |
|
$39.42M |
|
$9.15M |
|
$0.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.76 |
|
-- |
|
-- |
|
0.03 |
|
0.04 |
|
41.75% |
|
23.27% |
|
23.27% |
|
-- |
|
23.85% |
|
18.27% |
|
$9.26M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
0.78 |
|
0.64 |
|
140.31 |
|
5.64% |
|
5.91% |
|
4.23% |
|
5.45% |
|
$0.10 |
|
$0.01 |
|
$0.01 |
|